Encision Inc. (ECIA)
OTCMKTS · Delayed Price · Currency is USD
0.1400
0.00 (0.00%)
Dec 29, 2025, 9:30 AM EST
Encision Market Cap
Encision has a market cap or net worth of $2.36 million as of December 31, 2025. Its market cap has decreased by -54.37% in one year.
Market Cap
2.36M
Enterprise Value
3.82M
Revenue
6.30M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.14
Market Cap Chart
Since August 13, 1996, Encision's market cap has decreased from 46.95M to 2.36M, a decrease of -94.97%. That is a compound annual growth rate of -9.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 2.36M | -55.78% |
| Dec 23, 2024 | 5.34M | 6.83% |
| Dec 29, 2023 | 5.00M | -14.97% |
| Dec 30, 2022 | 5.88M | -66.20% |
| Dec 31, 2021 | 17.40M | 249.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 764.81M |
| Glass House Brands | 748.72M |
| Elite Pharmaceuticals | 537.07M |
| American Oncology Network | 394.40M |
| Northwest Biotherapeutics | 379.67M |
| CytoDyn | 353.44M |
| Silence Therapeutics | 292.85M |
| Nika Pharmaceuticals | 291.10M |